Archived 43: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age [2022-08-19]

ASEM 문헌 요약

Official National Advisory Committee on Immunization document (2022) on “Archived 43: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age [2022-08-19]”. NACI recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age: Methods, epidemiology, vaccine coverage, hybrid immunity, efficacy, immunogenicity, administration, safety, adverse events and more.

이 요약은 문서를 식별하는 데 도움이 됩니다. 임상 권고사항은 항상 공식 버전과 업데이트 날짜를 확인하십시오.